Proline dehydrogenase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
11
|
0.770 |
None |
1.000 |
11 |
10
|
1996 |
2014 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.500 |
None |
0.955 |
22 |
8
|
2004 |
2018 |
SCHIZOPHRENIA 4 (disorder)
|
disease |
|
Disease or Syndrome
|
1
|
7
|
0.500 |
strong |
1.000 |
3 |
7
|
2002 |
2005 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.310 |
None |
1.000 |
2 |
|
2007 |
2013 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.310 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.300 |
None |
0.500 |
2 |
|
2006 |
2006 |
Amino Acid Metabolism, Inherited Disorders
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Amino Acid Metabolism, Inborn Errors
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
20
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hyperprolinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
4
|
3
|
0.170 |
None |
1.000 |
7 |
2
|
2002 |
2014 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.110 |
None |
1.000 |
1 |
|
2012 |
2012 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.110 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amino acids measurement
|
group |
|
Laboratory Procedure
|
53
|
92
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
blood phenylalanine measurement by Guthrie microbiologic assay
|
phenotype |
|
Laboratory Procedure
|
4
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Leucine measurement
|
phenotype |
|
Laboratory Procedure
|
2
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Threonine measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
5
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Proline measurement
|
phenotype |
|
Laboratory Procedure
|
1
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Alanine measurement
|
phenotype |
|
Laboratory Procedure
|
3
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tyrosine measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
11
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Delayed speech and language development
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
560
|
192
|
0.100 |
None |
|
0 |
|
|
|
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.100 |
None |
|
0 |
|
|
|
HYPERGLYCINURIA (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
14
|
3
|
0.100 |
None |
|
0 |
|
|
|